FDA backs Pfizer COVID-19 boosters for seniors, high-risk
By MATTHEW PERRONE, LAURAN NEERGAARD and MIKE STOBBE (AP) — The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health